Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.


During the Trading Day
34.75 -0.05 / -0.14%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
34.84 +0.09 / +0.26%
Volume: 6.0K
Health Technology

Company Description

Grifols SA is a vertically integrated global producer of plasma derivatives. Its activities include sourcing raw material, manufacturing various plasma derivative products and selling and distributing final products to healthcare providers. The company operates through four segments: Bioessence, Hospital, Diagnostic and Raw Materials. The Bioessence segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by Group companies earmarked for hospital pharmacy. The Diagnostic segment includes the marketing of diagnostic testing equipment, reagents, and other equipment. The Raw Materials segment includes the sale of intermediate biological products and the rendering of manufacturing services to third party companies. Grifols was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.

Contact Information

Grifols SA
Avinguda de la Generalitat, 152-158
Barcelona Catalonia 08174
P:(493) 571-0500
Investor Relations:



Other institutional32.49%
Mutual fund holders27.02%
Individual stakeholders--

Top Executives

Víctor Grifols RouraChairman, President & Chief Executive Officer
Alfredo Arroyo GuerraChief Financial Officer & Vice President
Eva Bastida TubauVP, Director-Scientific & Medical Affairs
Antonio Viñes PáresVP, Director-Corporate Planning & Control
Carlos Roura FernandezVP & Co-President-Global Industrial Division